-transparent.png){kind=logo}
The growth hormone (GH), thyrotrophin (TSH) and prolactin response to growth hormone releasing factor (GRF) was investigated in 18 patients suffering from major depression with melancholia and in 18 age- and sex-matched normal controls. There was no significant difference in the GH response to GRF stimulation between the patients and controls and in neither subject group was there a demonstrable TSH or prolactin response to GRF. These findings indicate that the pathophysiology underlying the blunted GH response to pharmacological challenge, demonstrated in other studies, must lie at a suprapituitary level.
Related Publications
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
September 1988,
Psychiatry research,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
December 1987,
The Journal of clinical endocrinology and metabolism,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
May 1995,
The Journal of clinical endocrinology and metabolism,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
January 1987,
Acta paediatrica Scandinavica,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
March 1993,
Nihon Naibunpi Gakkai zasshi,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
August 1985,
Endocrinologia japonica,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
February 1996,
The Journal of clinical investigation,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
June 1995,
European journal of endocrinology,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
January 2005,
The Journal of clinical endocrinology and metabolism,
R Thomas, and
R Beer, and
B Harris, and
R John, and
M Scanlon
August 1986,
The Journal of clinical endocrinology and metabolism,
